26 March 2020
Japan plays a prominent role in advancing the global health agenda, especially since the G8 Summit in 2000 where infectious diseases control was extensively discussed and led to a decision to create The Global Fund. Japan has also been spearheading a number of innovative health initiatives such as a loan conversion mechanism for its long-standing polio eradication program support.
Currently, Japan is taking a leading role in promoting universal health coverage as the overarching approach for attaining SDG3. Japan made its first commitment to Gavi at the 2011 June pledging conference, committing USD 9.3 million in direct contributions for 2011 and maintained a similar level of annual contribution up until 2014.
In 2015, Japan doubled its contribution in support of health system recovery in the aftermath of the 2014 Ebola outbreaks. In May 2016. in the fringe of the G7 leaders’ Summit under its presidency, Japan for the first time announced a multi-year pledge to Gavi In 2019, Japan hosted the launch of Gavi’s third replenishment as part of TICAD 7 in Yokohama. At the Global Vaccine Summit in June 2020, Japan announced to commit USD 300 million to Gavi for 2021-2025, tripling its USD$ 130 million.
Contributions and pledges in total:
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2019 and Q1-Q3 2020 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2019 and Q1-Q3 2020 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020.
Future contributions (for pledges at the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020 and years
Future contributions: non-US$ contributions for Q4-2020 and for years 2021 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 September 2020
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2020, IFFIm donor grant payments are reduced by 0.5%, however such reductions are not reflected in future contributions figures.